Holen Sie sich die Stockscreener-App
3.44
3.37%
-0.12
Handel nachbörslich:
3.48
0.04
+1.16%
Schlusskurs vom Vortag:
$3.56
Offen:
$3.56
24-Stunden-Volumen:
751.81K
Relative Volume:
0.47
Marktkapitalisierung:
$195.08M
Einnahmen:
$195.82M
Nettoeinkommen (Verlust:
$-88.78M
KGV:
-1.3711
EPS:
-2.5089
Netto-Cashflow:
$-88.86M
1W Leistung:
-8.27%
1M Leistung:
-18.68%
6M Leistung:
-33.97%
1J Leistung:
-46.42%
1-Tages-Spanne:
$3.415
$3.57
1-Wochen-Bereich:
$3.28
$3.70
52-Wochen-Spanne:
$3.28
$6.83
Aurora Cannabis Inc. Stock (ACB) Company Profile
Firmenname
Aurora Cannabis Inc.
Sektor
Telefon
-
Adresse
10355 Jasper Avenue, Suite 500, Edmonton, AB
Compare ACB vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACB
Aurora Cannabis Inc.
|
3.44 | 201.89M | 195.82M | -88.78M | -88.86M | -2.5089 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-12-11 | Eingeleitet | TD Cowen | Buy |
| 2024-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-09-21 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2022-06-24 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-06-06 | Hochstufung | Stifel | Sell → Hold |
| 2021-09-28 | Hochstufung | MKM Partners | Sell → Neutral |
| 2021-09-03 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-05-14 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-05-14 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2021-05-11 | Herabstufung | CIBC | Neutral → Sector Underperform |
| 2021-04-28 | Fortgesetzt | BofA Securities | Neutral |
| 2021-02-12 | Herabstufung | Desjardins | Hold → Sell |
| 2021-02-12 | Herabstufung | MKM Partners | Neutral → Sell |
| 2021-02-12 | Herabstufung | Needham | Hold → Underperform |
| 2020-12-18 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2020-11-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-11-11 | Herabstufung | Stifel | Hold → Sell |
| 2020-10-27 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-21 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-24 | Hochstufung | Stifel | Sell → Hold |
| 2020-05-22 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-05-15 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2020-02-27 | Herabstufung | Bryan Garnier | Neutral → Sell |
| 2020-02-25 | Eingeleitet | Needham | Hold |
| 2020-02-24 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-02-14 | Hochstufung | MKM Partners | Sell → Neutral |
| 2020-02-07 | Herabstufung | Canaccord Genuity | Speculative Buy → Hold |
| 2020-01-10 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-23 | Herabstufung | Jefferies | Buy → Hold |
| 2019-11-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-09-24 | Eingeleitet | CIBC | Neutral |
Alle ansehen
Aurora Cannabis Inc. Aktie (ACB) Neueste Nachrichten
Promising Cannabis Stocks To ConsiderFebruary 11th - MarketBeat
Aurora Advances Global Medical Growth Strategy With Portfolio Expansion in Australia, New Zealand - Cannabis Business Times
Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand - The Globe and Mail
Aurora Cannabis expands medical portfolio in Australia and New Zealand - StreetInsider
Promising Cannabis Stocks To Watch TodayFebruary 10th - MarketBeat
Aurora Cannabis: 3Q Revenue Jumps on Strong Medical Sales – Quarterly Update Report - Yahoo Finance
Aurora Cannabis: 3Q Revenue Jumps on Strong Medical Sales – Downloadable Quarterly Report - Yahoo Finance
Best Cannabis Stocks To ResearchFebruary 9th - MarketBeat
Is Aurora Cannabis Inc impacted by rising ratesWeekly Investment Report & Stock Market Timing Techniques - baoquankhu1.vn
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Cannabis Stocks To Keep An Eye OnFebruary 8th - MarketBeat
Cannabis Stocks To ResearchFebruary 7th - MarketBeat
Aurora Cannabis (OTCMKTS:ACBFF) Shares Down 2.9%Here's What Happened - MarketBeat
Cannabis Stocks To Watch TodayFebruary 6th - MarketBeat
Should you sell your Aurora Cannabis stock? - Cantech Letter
Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release? - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Best Cannabis Stocks To Keep An Eye OnFebruary 5th - MarketBeat
Aurora Cannabis Launches US$100 Million At-the-Market Equity Program to Fund Growth - The Globe and Mail
Aurora Cannabis Stock Falls After Consumer Sales Plummet - 富途牛牛
Aurora Cannabis Inc. (NASDAQ:ACB) Q3 2026 Earnings Call Transcript - Insider Monkey
Stocks in play: Aurora Cannabis Inc. - Barchart.com
Aurora Cannabis Inc. (ACB): Investor Outlook With A Promising 69.98% Upside Potential - DirectorsTalk Interviews
Aurora Cannabis Q3 FY26 slides highlight record global medical revenue amid strategic expansion - Investing.com Australia
Aurora Cannabis shares dip after Q3 results show modest revenue growth - AlphaStreet News -
Aurora Cannabis Earnings Call Highlights Medical-First Pivot - TipRanks
Aurora Cannabis establishes $100 million at-the-market offering By Investing.com - Investing.com Australia
Promising Cannabis Stocks To Add to Your WatchlistFebruary 4th - MarketBeat
Aurora Cannabis (TSE:ACB) Hits New 1-Year LowShould You Sell? - MarketBeat
Aurora Cannabis Sets Up US$100 Million ATM Equity Program With TD Securities - TipRanks
Investor Outlook: Medical cannabis grows as U.S. reclassification nears - BNN Bloomberg
Aurora Cannabis Inc (ACB) (Q3 2026) Earnings Call Highlights: Strategic Shifts and Global ... By GuruFocus - Investing.com Canada
Aurora Cannabis Inc (ACB) (Q3 2026) Earnings Call Highlights: St - GuruFocus
'The company is one of the strongest balance sheets in the cannabis industry': Aurora Cannabis CEO - BNN Bloomberg
Aurora Cannabis (ACB) Q3 2026 Earnings Transcript - The Globe and Mail
Aurora Cannabis (NASDAQ:ACB) Posts Earnings Results - MarketBeat
Aurora Cannabis Q3 Earnings Call Highlights - MarketBeat
Aurora Cannabis Swings To A Loss In Q3 2026 On Record Medical Revenue - thedeepdive.ca
Q3 2026: Aurora to exit select Canadian consumer markets, doubles down on global medical business - StratCann
Aurora Cannabis (NASDAQ: ACB) launches U.S.$100M at-the-market share program - Stock Titan
Aurora Cannabis announces filing of prospectus supplement for at-the-market offering program - marketscreener.com
Earnings call transcript: Aurora Cannabis Q3 2026 shows revenue growth By Investing.com - Investing.com Canada
Aurora Cannabis Q3 FY26 slides highlight record global medical revenue amid strategic expansion By Investing.com - Investing.com South Africa
Earnings call transcript: Aurora Cannabis Q3 2026 shows revenue growth - Investing.com
Aurora Cannabis launches new websites for European customers - MMJDaily
Aurora Cannabis files prospectus for $100 million share offering program - StreetInsider
Aurora Cannabis Up In US Premarket On Q3 Revenue Beat and Bullish FY26 Expectations - 富途牛牛
Aurora Cannabis (ACB) Projects Significant Revenue Growth by FY2 - GuruFocus
Aurora (ACB) Posts Strong Q3 With Record Revenue And Increased E - GuruFocus
Insights into Aurora Cannabis Q3 Earnings - Benzinga
Aurora Cannabis Q3 Results Highlight Record Medical Revenue and Strategic Refocus on Core Markets - TipRanks
Finanzdaten der Aurora Cannabis Inc.-Aktie (ACB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.21%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):